The post-GLP-1 landscape has shifted consumer demand beyond calorie restriction toward muscle preservation and healthy longevity.
As nutrient density, metabolic health, and muscle preservation become increasingly important in healthy aging, muscle health is emerging as a key pillar of longevity-focused innovation.
This white paper explores how BiomeNrich® Post M005, an Akkermansia-derived postbiotic solution, can help brands address these evolving needs and unlock new opportunities in the longevity market.
Download the report to discover:
• Market Opportunity: How GLP-1 is reshaping expectations around muscle health and longevity.
• Formulation Advantage: Stable pasteurized Akkermansia for versatile applications without cell count degradation.
• Regulatory Confidence: The first NDIN-completed Akkermansia solution.
